These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 26663912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [Abstract] [Full Text] [Related]

  • 5. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
    Robinson AR, Kwek SS, Hagemeier SR, Wille CK, Kenney SC.
    J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
    [Abstract] [Full Text] [Related]

  • 6. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q.
    BMC Cancer; 2012 Mar 29; 12():125. PubMed ID: 22458933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.
    Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC.
    PLoS Pathog; 2009 Mar 29; 5(3):e1000356. PubMed ID: 19325883
    [Abstract] [Full Text] [Related]

  • 10. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A, Arteaga-Salas JM, Hammerschmidt W.
    PLoS Pathog; 2012 Sep 29; 8(9):e1002902. PubMed ID: 22969425
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
    Shi F, Shang L, Zhou M, Lv C, Li Y, Luo C, Liu N, Lu J, Tang M, Luo X, Xu J, Fan J, Zhou J, Gao Q, Wu W, Jia W, Wang H, Cao Y.
    J Med Virol; 2024 May 29; 96(5):e29634. PubMed ID: 38682578
    [Abstract] [Full Text] [Related]

  • 12. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR, Kwek SS, Kenney SC.
    PLoS Pathog; 2012 Feb 29; 8(2):e1002516. PubMed ID: 22346751
    [Abstract] [Full Text] [Related]

  • 13. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
    Bhende PM, Seaman WT, Delecluse HJ, Kenney SC.
    J Virol; 2005 Jun 29; 79(12):7338-48. PubMed ID: 15919888
    [Abstract] [Full Text] [Related]

  • 14. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.
    Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS.
    J Virol; 2014 Oct 29; 88(19):11442-58. PubMed ID: 25056883
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ, Chen YL, Chang Y, Wu CC, Ko YC, Tsao SW, Chen JY, Lin SF.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28490592
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S.
    J Virol; 2000 Feb 01; 74(3):1224-33. PubMed ID: 10627532
    [Abstract] [Full Text] [Related]

  • 17. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC.
    PLoS Pathog; 2021 Aug 01; 17(8):e1009783. PubMed ID: 34339458
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
    Wu CC, Chuang HY, Lin CY, Chen YJ, Tsai WH, Fang CY, Huang SY, Chuang FY, Lin SF, Chang Y, Chen JY.
    Mol Carcinog; 2013 Dec 01; 52(12):946-58. PubMed ID: 22641235
    [Abstract] [Full Text] [Related]

  • 19. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.
    Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28003489
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
    Eichelberg MR, Welch R, Guidry JT, Ali A, Ohashi M, Makielski KR, McChesney K, Van Sciver N, Lambert PF, Keleș S, Kenney SC, Scott RS, Johannsen E.
    mBio; 2019 Aug 20; 10(4):. PubMed ID: 31431547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.